Changes of B and T lymphocytes and selected apopotosis markers in Hashimoto's thyroiditis

Journal of Clinical Pathology

Volumn 64, Issue 7, 2011, Pages 626-630

  Kaczmarek, Elzbieta ^a   Lacka, Katarzyna ^a   Jarmolowska Jurczyszyn, Donata ^a   Sidor, Anna ^a   Majewski, Przemyslaw ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CASPASE 3; CD20 ANTIGEN; CD8 ANTIGEN; LEUKOSIALIN; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GOITER; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; T LYMPHOCYTE; THYROID FOLLICLE; THYROID FOLLICLE CELL;

APOPTOSIS; B-LYMPHOCYTES; FEMALE; HASHIMOTO DISEASE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 79959363276     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.086553     Document Type: Article

References (23)

1. Mitsiades N, Poulaki V, Kotoula V, et al. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis. J Clin Endokrinol Metab 1998;83:2199-203. (Pubitemid 28496359)
2. Fountoulakis S, Vartholomatos G, Kolaitis N, et al. Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis. Eur J Endocrinol 2008;156:853-9. (Pubitemid 351837374)
3. Wang SH, Van Antwerp M, Kuick R, et al. Microarray analysis of cytokine activation of apoptosis pathways in the thyroid. Endocrinology 2007;148:4844-52. (Pubitemid 47481524)
4. Chen S, Fazle Akbar SM, Zhen Z, et al. Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders. Cell Mol Immunol 2004;1:224-8.
5. Bossowski A, Czarnocka B, Stasiak-Barmuta A, et al. Analysis of Fas, FasL and caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases. Pol J Endocrinol 2007;58:303-13.
6. Myśliwiec J, Okota M, Nikołajuk A, et al. Age-related changes of soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases. Pol J Endocrinol 2007;58:492-5.
7. Mezosi E, Wang SH, Utsugi S, et al. Induction and regulation of Fas-mediated apoptosis in human thyroid epithelial cells. Mol Endocrinol 2005;19:804-11. (Pubitemid 40349450)
8. Nieruchalska E, Kaczmarek E, Jarmołowska-Jurczyszyn D, et al. Morphometrical analysis of immunohistochemical reaction of inflammatory infiltrate in chronic thyroiditis. Rocz Akad Med Bialymst 2004;49(Suppl 1):140-2.
9. Kie JH, Cho MS, Yang WI. Expression of CD40 and apoptosis related molecules in autoimmune thyroid disease. Yonsei Med J 2001;42:488-96.
10. Vendrame F, Segni M, Grassetti D, et al. Impaired caspase-3 expression by peripheral T cells in chronic autoimmune thyroiditis and in autoimmune polyendocrine syndrome-2. J Clin Endocrinol Metab 2006;91:5064-8. (Pubitemid 44917351)
11. Kaczmarek E, Lacka K, Majewski P, et al. Selected markers of proliferation and apoptosis in the parathyroid lesions: a spatial visualisation and quantification. J Mol Histol 2008;39:509-17.
12. Kaczmarek E, Strzelczyk R. From two to three-dimensional visualisation of structures in light and confocal microscopy - applications for biomedical studies. In: Mendez-Vilas A, Labajos-Broncano L, eds. FORMATEX microscopy book series No. II. Current issues on multidisciplinary microscopy research and education. Badajoz, 2005:289-95.
13. Myśliwiec J, Okota M, Nikołajuk A, et al. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers. Adv Med Sci 2006;51:119-22.
14. Xu WC, Chen SR, Huang JX, et al. Expression and distribution of S-100 protein, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in thyroid tissues of autoimmune thyroid diseases. Eur J Histochem 2007;51:291-300.
15. Wang SH, Bretz JD, Phelps E, et al. A Unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis; J Immunol 2002;168:2470-4. (Pubitemid 34171852)
16. Bretz JD, Arscott PL, Myc A, et al. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J Biol Chem 1999;274:25433-8.
17. Arscott PL, Knapp J, Rymaszewski M, et al. Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor. Endocrinology 1997;138:5019-27. (Pubitemid 27460943)
18. Denault JB, Eckelman BP, Shin H, et al. Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)dmediated inhibition of caspase 9. Biochem J 2007;405:11-19. (Pubitemid 46999920)
19. Baker JR Jr. Dying (Apoptosing?) for a consensus on the Fas death pathway in the thyroid. J Clin Endocrinol Metab 1999;84:2593-5.
20. Bretz JD, Mezosi E, Giordano TJ, et al. Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells. Cell Death Differ 2002;9:274-86. (Pubitemid 34223871)
21. Mezosi E, Yamazaki H, Bretz JD, et al. Aberrant apoptosis in thyroid epithelial cells from goiter nodules. J Clin Endocrinol Metab 2002;87:4264-72.
22. Mezosi E, Wang SH, Utsugi S, et al. Interleukin-1ß and tumor necrosis factor (TNF)-a sensitize human thyroid epithelial cells to TNF-related apoptosis-inducing ligand-induced apoptosis through increases in procaspase-7 and bid, and the down-regulation of p44/42 mitogen-activated protein kinase activity. J Clin Endocrinol Metab 2004;89:250-7. (Pubitemid 38183890)
23. Mezosi E, Wang SH, Utsugi S, et al. Induction and regulation of Fas-mediated apoptosis in human thyroid epithelial cells. Mol Endocrinol 2005;19:804-11. (Pubitemid 40349450)